A detailed history of Parkman Healthcare Partners LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 545,751 shares of TERN stock, worth $3.2 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
545,751
Previous 390,270 39.84%
Holding current value
$3.2 Million
Previous $2.66 Million 71.28%
% of portfolio
0.64%
Previous 0.39%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.49 - $10.8 $1.01 Million - $1.68 Million
155,481 Added 39.84%
545,751 $4.55 Million
Q2 2024

Aug 14, 2024

BUY
$4.54 - $8.2 $1.77 Million - $3.2 Million
390,270 New
390,270 $2.66 Million
Q3 2023

Nov 14, 2023

SELL
$4.7 - $8.55 $285,275 - $518,959
-60,697 Reduced 59.26%
41,728 $209,000
Q2 2023

Aug 11, 2023

BUY
$7.35 - $13.29 $201,573 - $364,478
27,425 Added 36.57%
102,425 $896,000
Q1 2023

May 12, 2023

BUY
$7.91 - $12.0 $593,250 - $900,000
75,000 New
75,000 $888,000

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $220M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.